HHMI unveils early career appointments

The Howard Hughes Medical Institute (HHMI) is opening a $300 million linkurl:competition;http://www.hhmi.org/news/earlycareer20080310.html today for early career scientists. As many as 70 scientists will receive six year, non-renewable appointments with HHMI. The competition is open to tenured or tenure-track researchers between the second and sixth year of their appointment. Applicants are required to submit an intention to apply letter by April 30, 2008, and send in a completed application by

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The Howard Hughes Medical Institute (HHMI) is opening a $300 million linkurl:competition;http://www.hhmi.org/news/earlycareer20080310.html today for early career scientists. As many as 70 scientists will receive six year, non-renewable appointments with HHMI. The competition is open to tenured or tenure-track researchers between the second and sixth year of their appointment. Applicants are required to submit an intention to apply letter by April 30, 2008, and send in a completed application by June 10. The next chance for this award won't come around until 2011.Correction: When originally posted, the article referred to HHMI "grants" rather than "appointments." The HHMI will employ the scientists for a 6 year term. Early career scientists will not receive a grant. The Scientist regrets the error.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Edyta Zielinska

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide